Second, although we demonstrated that TFAP2A regulates CES3 expression and influences lipid metabolism in NSCLC cells, the detailed molecular mechanisms by which the TFAP2A/CES3 axis modulates key lipid metabolism regulators such as FABP4 and ATGL remain unclear and warrant further investigation. The gene discussed is TFAP2A; the disease is non-small cell lung carcinoma.